Literature DB >> 8626025

The activity of D-raf in torso signal transduction is altered by serine substitution, N-terminal deletion, and membrane targeting.

K H Baek1, J R Fabian, F Sprenger, D K Morrison, L Ambrosio.   

Abstract

The Raf family of serine/threonine kinases are essential components in many receptor tyrosine kinase-mediated signal transduction pathways. Here, we analyze the function of D-raf in the Torso (Tor) pathway required to specify cellular fates at the embryonic poles. Using mutant embryos lacking endogenous D-raf protein, we show that D-raf's serine/threonine kinase activity is essential for its role in Tor signal transduction and that human Raf-1 will substitute for D-raf in this pathway. After Tor activation, D-raf becomes hyperphosphorylated. We identified two putative serine phosphorylation sites (S388 and S743) in SF9 cells and demonstrate that S743 or its phosphorylation is essential for D-raf function in embryos. Alanine substitution at S388, N-terminal truncation, or targeted membrane association permits transmission of the Torso signal by D-raf, but these D-raf molecules differ in their rescuing potential and relative biological activity. Membrane-targeted D-raftor4021 showed the highest level of activity, followed by alanine-substituted D-rafS388A and N-terminal-truncated D-raf delta 445. Since the activity profiles for these altered forms of D-raf are distinct, these findings indicate that each structural modification differentially affects the regulation and/or propagation of the Tor signal by these mutant D-raf proteins.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8626025     DOI: 10.1006/dbio.1996.0107

Source DB:  PubMed          Journal:  Dev Biol        ISSN: 0012-1606            Impact factor:   3.582


  9 in total

1.  14-3-3 antagonizes Ras-mediated Raf-1 recruitment to the plasma membrane to maintain signaling fidelity.

Authors:  Yvonne Light; Hugh Paterson; Richard Marais
Journal:  Mol Cell Biol       Date:  2002-07       Impact factor: 4.272

2.  Drosophila Raf's N terminus contains a novel conserved region and can contribute to torso RTK signaling.

Authors:  Jian Ding; Oren Tchaicheeyan; Linda Ambrosio
Journal:  Genetics       Date:  2009-12-14       Impact factor: 4.562

3.  14-3-3 facilitates Ras-dependent Raf-1 activation in vitro and in vivo.

Authors:  S Roy; R A McPherson; A Apolloni; J Yan; A Lane; J Clyde-Smith; J F Hancock
Journal:  Mol Cell Biol       Date:  1998-07       Impact factor: 4.272

4.  Characterization of maternal and zygotic D-raf proteins: dominant negative effects on Torso signal transduction.

Authors:  K Radke; K H Baek; L Ambrosio
Journal:  Genetics       Date:  1997-01       Impact factor: 4.562

5.  Caenorhabditis elegans CNK-1 promotes Raf activation but is not essential for Ras/Raf signaling.

Authors:  Christian E Rocheleau; Agneta Rönnlund; Simon Tuck; Meera V Sundaram
Journal:  Proc Natl Acad Sci U S A       Date:  2005-08-05       Impact factor: 11.205

6.  Drosophila-raf acts to elaborate dorsoventral pattern in the ectoderm of developing embryos.

Authors:  K Radke; K Johnson; R Guo; A Davidson; L Ambrosio
Journal:  Genetics       Date:  2001-11       Impact factor: 4.562

7.  A non-canonical Raf function is required for dorsal-ventral patterning during Drosophila embryogenesis.

Authors:  Jay B Lusk; Ellora Hui Zhen Chua; Prameet Kaur; Isabelle Chiao Han Sung; Wen Kin Lim; Vanessa Yuk Man Lam; Nathan Harmston; Nicholas S Tolwinski
Journal:  Sci Rep       Date:  2022-05-10       Impact factor: 4.996

8.  USP7 regulates the ERK1/2 signaling pathway through deubiquitinating Raf-1 in lung adenocarcinoma.

Authors:  Hong-Beom Park; Sohyun Hwang; Kwang-Hyun Baek
Journal:  Cell Death Dis       Date:  2022-08-10       Impact factor: 9.685

9.  Raf activation is regulated by tyrosine 510 phosphorylation in Drosophila.

Authors:  Fan Xia; Jinghong Li; Gavin W Hickey; Amy Tsurumi; Kimberly Larson; Dongdong Guo; Shian-Jang Yan; Louis Silver-Morse; Willis X Li
Journal:  PLoS Biol       Date:  2008-05-20       Impact factor: 8.029

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.